CD-Markers as an immunological aspect in patients with visceral leishmaniasis

CD-Markers as an immunological aspect in patients with visceral leishmaniasis

Back ground: Visceral leishmaniasis is an endemic protozoan disease in Iraq. Recovery from this disease confers a solid and permanent immunity. Immunological assessment of our patients was carried out and the results showed a significant reduction in the percentage of CD3, CD56 and a significant in...

Full description

Bibliographic Details
Main Authors:	Jabbar R. Zangor Al-Autabbi, Zainab A. Hamed. Al-Rubayee
Format:	Article
Language:	English
Published:	Faculty of Medicine University of Baghdad 2010-01-01
Series:	مجلة كلية الطب
Subjects:	CD-Markers profile, leishmania donovani, amastigote form
Online Access:	http://iqjmc.uobaghdad.edu.iq/index.php/19JFacMedBaghdad36/article/view/1096

Similar Items

Supplementation of host response by targeting nitric oxide to the macrophage cytosol is efficacious in the hamster model of visceral leishmaniasis and adds to efficacy of amphotericin B
by: Sanketkumar Pandya, et al.
Published: (2016-08-01)

Evolutionary genomics of epidemic visceral leishmaniasis in the Indian subcontinent
by: Hideo Imamura, et al.
Published: (2016-03-01)

A comparative morphometrics of amastigote forms of <em>Leishmania donovani</em> found in cutaneous leishmaniasis patients in Sri Lanka: evidence for the presence of promastigote-like structures
by: A Gunasekara, et al.
Published: (2019-04-01)

Visceral Leishmaniasis, Northern Somalia, 2013–2019
by: Mikko K. Aalto, et al.
Published: (2020-01-01)

Study of the stress proteins secreted by Leishmania donovani after treatment with edelfosine, mitelfosine and ilmofosine, and morphological alterations analyzed by electronic microscopy
by: Azzouz S., et al.
Published: (2009-09-01)

CUTANEOUS LEISHMANIASIS: AN EXPERIENCE AT UMDC
by: Tabinda Roheen, et al.
Published: (2014-12-01)

Histopathological alterations in the reproductive tract of male dogs with Canine Visceral Leishmaniasis
by: Andrea Lantiere Correa de Barros, et al.
Published: (2019-04-01)

Immunotherapy and immunochemotherapy in visceral leishmaniasis: promising treatments for this neglected disease
by: Bruno Mendes Roatt, et al.
Published: (2014-06-01)

Evaluation of antibody responses in american visceral leishmaniasis by ELISA and immunoblot Avaliação da resposta imune humoral na leishmaniose visceral americana pelos métodos ELISA e "immunoblot"
by: Thomas G. Evans, et al.
Published: (1989-06-01)

Studies Aimed at the Synthesis of Anti-Infective Agents
by: Kanwar, Ankush
Published: (2018)

Immunobiology of visceral leishmaniasis
by: Susanne eNylén, et al.
Published: (2012-08-01)

Domestic Animals and Epidemiology of Visceral Leishmaniasis, Nepal
by: Narayan Raj Bhattarai, et al.
Published: (2010-02-01)

Measures to Control Phlebotomus argentipes and Visceral Leishmaniasis in India
by: Richard M. Poché, et al.
Published: (2016-05-01)

Sero-prevalence of visceral leishmaniasis (VL) among dogs in VL endemic areas of Mymensingh district, Bangladesh
by: Ariful Islam, et al.
Published: (2017-09-01)

Active cutaneous leishmaniasis in Brazil, induced by Leishmania donovani chagasi
by: M. P. Oliveira Neto, et al.
Published: (1986-09-01)

Parameter Estimation and Mathematical Modeling of Visceral Leishmaniasis Transmission
Published: (2016)

The anti-tubercular drug delamanid as a potential oral treatment for visceral leishmaniasis
by: Stephen Patterson, et al.
Published: (2016-05-01)

Viscerotropic potential of parasites isolated from post-kala-azar dermal leishmaniasis cases : An experimental evidence
by: A.K. Gupta, S. Narayan, N. Verma, A.K. Thakur & P. Das
Published: (2012-12-01)

Clinical and epidemiological characteristics of cutaneous leishmaniasis in Sri Lanka
by: Devika Iddawela, et al.
Published: (2018-03-01)

Effect of thiadiazine derivatives on intracellular amastigotes of Leishmania amazonensis
by: Lianet Monzote Fidalgo, et al.
Published: (2004-05-01)

Differential Expression of miRNA Regulates T Cell Differentiation and Plasticity during Visceral Leishmaniasis Infection
by: Rajan ePandey, et al.
Published: (2016-02-01)

Resistance to visceral leishmaniasis is severely compromised in mice deficient of bradykinin B2-receptors
by: Nico Dirlei, et al.
Published: (2012-11-01)

Is leishmaniasis in Sri Lanka benign and be ignored?
by: N.D. Karunaweera, et al.
Published: (2009-02-01)

Urine-Based Antigen (Protein) Detection Test for the Diagnosis of Visceral Leishmaniasis
by: Antonio Campos-Neto, et al.
Published: (2020-10-01)

Visceral Leishmaniasis Caused by Leishmania donovani Zymodeme MON-37, Western Ghats, India
by: Prasanta Saini, et al.
Published: (2020-08-01)

Leishmaniose visceral em um canino de Cruz Alta, Rio Grande do Sul, Brasil Visceral leishmaniasis in a dog in Cruz Alta, Rio Grande do Sul, south Brazil
by: Cristina Krauspenhar, et al.
Published: (2007-06-01)

Primary laryngeal leishmaniasis: A rare case report
by: Kumar Bipin, et al.
Published: (2009-01-01)

Ribosome Profiling Reveals HSP90 Inhibitor Effects on Stage-Specific Protein Synthesis in Leishmania donovani
by: Eugenia Bifeld, et al.
Published: (2018-11-01)

Detection of amastigote-like forms in the valve of Phlebotomus papatasi infected with Leishmania major
by: Nestor Añez, et al.
Published: (2003-06-01)

Genetic diversity analysis of Chinese Leishmania isolates and development of L. donovani complex-specific markers by RAPD
by: Dongmei Yuan, et al.
Published: (2021-05-01)

Activité et évaluation thérapeutique de dérivés furanosidiques sur le parasite Leishmania donovani
by: Ory, Kévin
Published: (2019)

New diarylsulfonamide inhibitors of Leishmania infantum amastigotes
by: Myriam González, et al.
Published: (2021-08-01)

Obtención y mantenimiento en cultivo de amastigotes axénicos de Leishmania peruviana y Leishmania brazilensis
by: Jesús Rojas Jaimes, et al.
Published: (2020-09-01)

IL-4 Mediated Resistance of BALB/c Mice to Visceral Leishmaniasis Is Independent of IL-4Rα Signaling via T Cells
by: Emma McFarlane, et al.
Published: (2019-08-01)

Peptides to Tackle Leishmaniasis: Current Status and Future Directions
by: Alberto A. Robles-Loaiza, et al.
Published: (2021-04-01)

Fe3O4@piroctone olamine magnetic nanoparticles: Synthesize and therapeutic potential in cutaneous leishmaniasis
by: Aishah E. Albalawi, et al.
Published: (2021-07-01)

Evaluación de una prueba de aglutinación directa como método alternativo para el diagnóstico de leishmaniasis visceral canina y humana en Venezuela
by: Guillermo Terán-Angel, et al.
Published: (2007-09-01)

Parasite load and its association with disease outcome in cutaneous leishmaniasis in Sri Lanka
by: F. H. Riyal, et al.
Published: (2021-04-01)

Analysis and chromosomal mapping of Leishmania (Leishmania) amazonensis amastigote expressed sequence tags
by: Luciana Girotto Gentil, et al.
Published: (2007-09-01)

Histopathological patterns of the liver involvement in visceral leishmaniasis
by: M. I. S. Duarte, et al.
Published: (1987-06-01)